Literature DB >> 11997440

A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease.

Richard T Cummings1, Scott P Salowe, Barry R Cunningham, Judyann Wiltsie, Young Whan Park, Lisa M Sonatore, Douglas Wisniewski, Cameron M Douglas, Jeffrey D Hermes, Edward M Scolnick.   

Abstract

A fluorescence resonance energy transfer assay has been developed for monitoring Bacillus anthracis lethal factor (LF) protease activity. A fluorogenic 16-mer peptide based on the known LF protease substrate MEK1 was synthesized and found to be cleaved by the enzyme at the anticipated site. Extension of this work to a fluorogenic 19-mer peptide, derived, in part, from a consensus sequence of known LF protease targets, produced a much better substrate, cleaving approximately 100 times more efficiently. This peptide sequence was modified further on resin to incorporate donor/quencher pairs to generate substrates for use in fluorescence resonance energy transfer-based appearance assays. All peptides cleaved at similar rates with signal/background ranging from 9-16 at 100% turnover. One of these substrates, denoted (Cou)Consensus(K(QSY-35)GG)-NH(2), was selected for additional assay optimization. A plate-based assay requiring only low nanomolar levels of enzyme was developed for screening and inhibitor characterization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997440      PMCID: PMC124449          DOI: 10.1073/pnas.062171599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

Review 1.  Anthrax.

Authors:  T C Dixon; M Meselson; J Guillemin; P C Hanna
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

2.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

3.  Crystal structure of the anthrax lethal factor.

Authors:  A D Pannifer; T Y Wong; R Schwarzenbacher; M Renatus; C Petosa; J Bienkowska; D B Lacy; R J Collier; S Park; S H Leppla; P Hanna; R C Liddington
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

4.  Lethal factor active-site mutations affect catalytic activity in vitro.

Authors:  S E Hammond; P C Hanna
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Authors:  N S Duesbery; C P Webb; S H Leppla; V M Gordon; K R Klimpel; T D Copeland; N G Ahn; M K Oskarsson; K Fukasawa; K D Paull; G F Vande Woude
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

6.  Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

Authors:  G Vitale; L Bernardi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 7.  Anthrax.

Authors:  M Mock; A Fouet
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

8.  Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.

Authors:  G Vitale; R Pellizzari; C Recchi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

  8 in total
  30 in total

1.  Progress in rapid screening of Bacillus anthracis lethal factor activity.

Authors:  Michèle Mock; Bernard P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

2.  Enzyme-mediated individual nanoparticle release assay.

Authors:  James R Glass; Janet C Dickerson; David A Schultz
Journal:  Anal Biochem       Date:  2006-03-31       Impact factor: 3.365

3.  Gold nanoparticles-based protease assay.

Authors:  Cristian Guarise; Lucia Pasquato; Vincenzo De Filippis; Paolo Scrimin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-01       Impact factor: 11.205

4.  Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor.

Authors:  Arpita Agrawal; César Augusto F de Oliveira; Yuhui Cheng; Jennifer A Jacobsen; J Andrew McCammon; Seth M Cohen
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

5.  Yeast display evolution of a kinetically efficient 13-amino acid substrate for lipoic acid ligase.

Authors:  Sujiet Puthenveetil; Daniel S Liu; Katharine A White; Samuel Thompson; Alice Y Ting
Journal:  J Am Chem Soc       Date:  2009-11-18       Impact factor: 15.419

6.  Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.

Authors:  Matthew J Saunders; Bruce S Edwards; Jingshu Zhu; Larry A Sklar; Steven W Graves
Journal:  Curr Protoc Cytom       Date:  2010-10

7.  Small molecule inhibitors of anthrax lethal factor toxin.

Authors:  John D Williams; Atiyya R Khan; Steven C Cardinale; Michelle M Butler; Terry L Bowlin; Norton P Peet
Journal:  Bioorg Med Chem       Date:  2013-11-13       Impact factor: 3.641

Review 8.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

9.  Substrate recognition of anthrax lethal factor examined by combinatorial and pre-steady-state kinetic approaches.

Authors:  Maria Yu Zakharova; Nikita A Kuznetsov; Svetlana A Dubiley; Arina V Kozyr; Olga S Fedorova; Dmitry M Chudakov; Dmitry G Knorre; Igor G Shemyakin; Alexander G Gabibov; Alexander V Kolesnikov
Journal:  J Biol Chem       Date:  2009-04-09       Impact factor: 5.157

10.  Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.

Authors:  Sherida L Johnson; Li-Hsing Chen; Elisa Barile; Aras Emdadi; Mojgan Sabet; Hongbin Yuan; Jun Wei; Donald Guiney; Maurizio Pellecchia
Journal:  Bioorg Med Chem       Date:  2009-03-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.